Confirm Biosciences
Confirm Biosciences is a San Diego-based diagnostics manufacturer founded in 2008 that produces and distributes instant urine, fertility, and consumer health tests through commercial channels with 101-250 employees.
- Company typePrivate
- Founded2008
- HeadquartersSan Diego, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Confirm Biosciences does
Confirm Biosciences is a private, for-profit diagnostics manufacturer founded in 2008 and headquartered in San Diego, California. According to the available firmographic data, the company manufactures and distributes instant diagnostic tests — specifically urine tests, fertility tests, and other consumer health tests — indicating a product portfolio oriented toward over-the-counter or point-of-care use rather than centralized laboratory testing. With a reported headcount of 101-250 employees, the company appears to operate at commercial scale, suggesting established manufacturing, distribution, and possibly regulatory/quality functions consistent with selling regulated diagnostic products in the US market.
The company's business model is consistent with a consumer diagnostics OEM/brand model: it produces physical test kits and moves them through distribution channels (retail, pharmacy, wholesale, or direct) to end users, generating revenue on a per-unit basis. Two financing rounds were disclosed in the input — a 2019 round (Round 4) led by HCAP Partners and a 2020 round — providing capital for ongoing operations and likely growth. Co-founder Serhat Pala is listed as a Special Advisor, suggesting a transition away from day-to-day operational leadership.
Direct evidence on revenue, specific customer relationships, partnerships, certifications, and product-level technology was not available in the input. The company's website displayed a loading/verification page at the time of data collection, limiting the ability to verify product details, regulatory clearances, or channel strategy. As a result, the description above reflects only what is directly supported by the input; deeper conclusions on commercial performance, regulatory status, and go-to-market specifics would require primary-source verification.
Confirm Biosciences firmographics
Firmographics- Name
- Confirm Biosciences
- Website
- https://confirmbiosciences.com
- Company type
- Private
- Founded year
- 2008
- Headcount range
- 101–250 employees
- Short description
- Confirm Biosciences is a San Diego-based diagnostics manufacturer founded in 2008 that produces and distributes instant urine, fertility, and consumer health tests through commercial channels with 101-250 employees.
- Ownership category
- akta.pro rank
Confirm Biosciences industry classification
Industry- Product category
- Diagnostic Test Kits
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels) (HLAHAOAG)
- akta.pro secondary industries
- Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection) (HLAHAOAF), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)
Keywords
Where Confirm Biosciences is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Confirm Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Confirm Biosciences product offering
Product offeringCore offering
Confirm Biosciences manufactures and distributes instant diagnostic test kits, including urine drug tests, fertility tests, and general health tests. Founded in 2008 in San Diego, the company produces rapid point-of-use diagnostic products that deliver on-the-spot results for drug screening, reproductive health, and general wellness applications.
Differentiator
Problem solved
Functional benefit
Products and services
- Urine Drug Test Kits
Companies that use Confirm Biosciences
Customer profileIdeal customer profiles2 records
Confirm Biosciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Confirm Biosciences partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Confirm Biosciences competitors and assessment
Company assessmentEmerging players
- EKF Diagnostics: Mid-market diagnostics company offering point-of-care rapid tests including drug-of-abuse and women's health — comparable in scale and product overlap to Confirm.
- Wondfo Biotech: Rapid diagnostics manufacturer with a strong fertility/pregnancy and drug-of-abuse catalog, increasingly competing in U.S. POCT channels alongside Confirm.
Broad incumbents
- Trinity Biotech: Public diagnostics company with a rapid-test portfolio (drugs of abuse, infectious disease) overlapping Confirm's product lines and end markets.
- QuidelOrtho: Major IVD/POCT manufacturer (Triage, QuickVue, Sofia) with overlapping rapid-test product lines across drugs-of-abuse, infectious disease, and women's health — directly comparable to Confirm Biosciences' rapid diagnostics portfolio.
- Abbott Diagnostics: Global diagnostics leader with rapid POC tests (Binax, Alere i) and a large urine drug-screening franchise — competes with Confirm in the same customer channels.
- Becton, Dickinson and Company (BD): Owns BD Veritor and a substantial drug-of-abuse / workplace testing business; broadly overlapping with Confirm's urine drug-test and rapid-diagnostics offerings.
Direct peers
- Premier Biotech: Mid-sized U.S. drug-testing cup and POCT manufacturer with workforce and clinical customers very similar to Confirm Biosciences' go-to-market.
- OraSure Technologies: Specialist in rapid oral-fluid and urine-based tests for drugs of abuse and infectious disease — the closest mid-cap pure-play comparable to Confirm Biosciences.
- ACON Laboratories: Manufacturer of rapid diagnostic tests including fertility/pregnancy and drug-of-abuse products, with similar product breadth and customer segments to Confirm.
- Sekisui Diagnostics (OSOM): Rapid test maker (OSOM brand) covering hCG/ovulation, Strep, flu and drugs of abuse — competes head-to-head in women's-health and clinical POCT categories.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Confirm Biosciences social profiles
Digital presenceConfirm Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Confirm Biosciences leadership team
Management profileNumber of profiles
Profiles1 record
Confirm Biosciences funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Confirm Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Confirm Biosciences
What does Confirm Biosciences do?
Confirm Biosciences manufactures and distributes instant diagnostic test kits, including urine drug tests, fertility tests, and general health tests. Founded in 2008 in San Diego, the company produces rapid point-of-use diagnostic products that deliver on-the-spot results for drug screening, reproductive health, and general wellness applications.
Is Confirm Biosciences a public or private company?
Confirm Biosciences is a private company. It is classified as founder individual operated bootstrapped.
When was Confirm Biosciences founded?
Confirm Biosciences was founded in 2008. It employs 101 to 250 people.
Where is Confirm Biosciences based?
Confirm Biosciences is headquartered in San Diego, United States, in the North America region.
Who are Confirm Biosciences's main competitors?
Emerging players on record are EKF Diagnostics and Wondfo Biotech. Broad incumbents are Trinity Biotech, QuidelOrtho, Abbott Diagnostics and Becton, Dickinson and Company (BD). Direct peers are Premier Biotech, OraSure Technologies, ACON Laboratories and Sekisui Diagnostics (OSOM).
Does Confirm Biosciences have an API?
No public API is recorded for Confirm Biosciences.
What industry is Confirm Biosciences in?
Confirm Biosciences's product category is Diagnostic Test Kits. Its primary akta.pro industry code is HLAHAOAG, Drug-of-Abuse & Toxicology Rapid Tests (Urine/saliva panels), with a secondary code of HLAHAOAF, Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection). Its NAICS code is 325413 and its SIC code is 2835.